Rennova Health, Inc. (RNVA)

Rennova Health Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Thursday, April 17, 2025.

Earnings Date	Apr 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-93.49%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.16

Current Ratio	0.16
Quick Ratio	0.09
Debt / Equity	n/a
Debt / EBITDA	5.83
Debt / FCF	3.88
Interest Coverage	0.94

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	4.18%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-6.14%
Revenue Per Employee	151,917
Profits Per Employee	-62,839
Employee Count	149
Asset Turnover	0.92
Inventory Turnover	34.37

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	53.11
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.96
Average Volume (20 Days)	1,403,628

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Rennova Health had revenue of 18.69 million and -7.73 million in losses. Loss per share was -0.00.

Revenue	18.69M
Gross Profit	11.11M
Operating Income	1.37M
Pretax Income	-314,044
Net Income	-7.73M
EBITDA	1.68M
EBIT	1.37M
Loss Per Share	-0.00

Balance Sheet

The company has 49,015 in cash and 11.78 million in debt, giving a net cash position of -11.73 million.

Cash & Cash Equivalents	49,015
Total Debt	11.78M
Net Cash	-11.73M
Net Cash Per Share	n/a
Equity (Book Value)	-36.84M
Book Value Per Share	-0.00
Working Capital	-35.56M

Cash Flow

In the last 12 months, operating cash flow was 3.39 million and capital expenditures -350,934, giving a free cash flow of 3.04 million.

Operating Cash Flow	3.39M
Capital Expenditures	-350,934
Free Cash Flow	3.04M
FCF Per Share	n/a

Margins

Gross margin is 59.46%, with operating and profit margins of 7.31% and -41.36%.

Gross Margin	59.46%
Operating Margin	7.31%
Pretax Margin	-1.68%
Profit Margin	-41.36%
EBITDA Margin	8.97%
EBIT Margin	7.31%
FCF Margin	16.25%

Dividends & Yields

Rennova Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-228.51%
Shareholder Yield	-228.51%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on March 16, 2022. It was a reverse split with a ratio of 0.0001.

Last Split Date	Mar 16, 2022
Split Type	Reverse
Split Ratio	0.0001

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a